A Closer Look at Decision-Making Process and the Potential of HTA for Health System Strengthening in Laos Nonthaburi, Thailand—April 30, 2025— A newly published study “Situation analysis of evidence-informed health decision-making in Lao PDR: the case of health technology assessm

Katika Akksilp MD PhD is a researcher at the Institute of Medical Research and Technology Assessment and currently serves as Head of the Precise Interventions (PI) unit at Health Intervention and Technology Assessment Program (HITAP) Foundation. He earned his doctorate in Public Health Research from Saw Swee Hock School of Public Health, National U

“What’s the value added I’m offering to the existing world of books and literature?” It is the mantra to keep in mind, repeating every few hours in my head when writing chapters to a book or even a paper. This is what I take home from the HITAP organized ‘Best Buys, Wasted Buys and Controversies in

Low- and middle-income countries (LMICs) bear the major brunt of the non-communicable disease (NCD) burden. Taking control of and reducing this burden is at the forefront of the global health agenda. But how do countries go about doing this? Well, that is a good question.One way is through intervent

Ryan Jonathan Sitanggang is an International Cooperation Officer (ICO) at the International Unit of the HITAP Foundation. He works on strengthening HTA networks and systems across Asia through initiatives such as the Asia HTA Registry, the HTAsiaLink Strategic Plan, and regional capacity-building. His role includes managing partnerships, coordinati

HITAP emphasise the lead role of Thailand in public health system as the host of the Health Technology Assessment (HTA) conference at the regional level gathering around 300 academics from 20 countries to present their research work, build a network for health policy recommendations development, and

Abstract Background: High levels of sedentary behaviour (SB) are associated with non-communicable diseases. In 2016, the estimated total healthcare expenditure from physical activity (PA) in Thailand added up to $190 million in international dollars. The challenge to reduce SB and increase PA amo

In the largest settlement involving a pharmaceutical company, the British drugmaker GlaxoSmithKline agreed to plead guilty to criminal charges and pay $3 billion in fines for promoting its best-selling antidepressants for unapproved uses and failing to report safety data about a top diabetes drug, f